Global Single-cell Omics 麻豆原创 Research Report 2025

Publication ID:

PB504252817

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Single-cell Omics was valued at US$ 1951 million in the year 2024 and is projected to reach a revised size of US$ 5542 million by 2031, growing at a CAGR of 16.3% during the forecast period.
Omics is a term summarizing different comprehensive molecular analyses, such as genomics, transcriptomics, proteomics, lipidomics or metabolomics. Transcriptomics for example does not only analyze the expression of a single gene, but investigates the expression pattern of many or even all genes. Omics analyses have been performed across whole tissues or organs. Today, with emerging technologies in single cell isolation and more sensitive molecular technologies, omics analyses can also be conducted at single cells resolution. These so called single cell omics analyses are providing unique insights into the heterogeneity of cells across tissues.
New advances in single-cell technologies are facilitating the opportunity to discern biological insights within individual cells. Moreover, the newer single-cell platforms have fueled cellular separation and analysis capabilities that have created higher interest among researchers, particularly in the arena of individual cellular genomics. Thus, the evolving demand for novel single-cell analysis platforms is pushing manufacturers to launch innovative products in the market.
This report aims to provide a comprehensive presentation of the global market for Single-cell Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-cell Omics.
The Single-cell Omics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single-cell Omics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-cell Omics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
ANGLE Plc
BD
Bio-Rad Laboratories, Inc.
Biognosys
CELLENION
CYTENA GmbH
Danaher Corporation
Illumina, Inc.
Mission Bio
PerkinElmer Inc.
Standard BioTools Inc.
Vizgen
10x Genomics
Segment by Type
Single-Cell Genomics
Single-Cell Transcriptomics
Single-Cell Proteomics
Single-Cell Metabolomics
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic and Research Organizations
Hospital and Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-cell Omics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Single-cell Omics 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single-Cell Genomics
1.2.3 Single-Cell Transcriptomics
1.2.4 Single-Cell Proteomics
1.2.5 Single-Cell Metabolomics
1.3 麻豆原创 by Application
1.3.1 Global Single-cell Omics 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic and Research Organizations
1.3.4 Hospital and Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-cell Omics 麻豆原创 Perspective (2020-2031)
2.2 Global Single-cell Omics Growth Trends by Region
2.2.1 Global Single-cell Omics 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Single-cell Omics Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Single-cell Omics Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Single-cell Omics 麻豆原创 Dynamics
2.3.1 Single-cell Omics Industry Trends
2.3.2 Single-cell Omics 麻豆原创 Drivers
2.3.3 Single-cell Omics 麻豆原创 Challenges
2.3.4 Single-cell Omics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-cell Omics Players by Revenue
3.1.1 Global Top Single-cell Omics Players by Revenue (2020-2025)
3.1.2 Global Single-cell Omics Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Single-cell Omics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single-cell Omics Revenue
3.4 Global Single-cell Omics 麻豆原创 Concentration Ratio
3.4.1 Global Single-cell Omics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-cell Omics Revenue in 2024
3.5 Global Key Players of Single-cell Omics Head office and Area Served
3.6 Global Key Players of Single-cell Omics, Product and Application
3.7 Global Key Players of Single-cell Omics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-cell Omics Breakdown Data by Type
4.1 Global Single-cell Omics Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Single-cell Omics Forecasted 麻豆原创 Size by Type (2026-2031)
5 Single-cell Omics Breakdown Data by Application
5.1 Global Single-cell Omics Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Single-cell Omics Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Single-cell Omics 麻豆原创 Size (2020-2031)
6.2 North America Single-cell Omics 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Single-cell Omics 麻豆原创 Size by Country (2020-2025)
6.4 North America Single-cell Omics 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-cell Omics 麻豆原创 Size (2020-2031)
7.2 Europe Single-cell Omics 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Single-cell Omics 麻豆原创 Size by Country (2020-2025)
7.4 Europe Single-cell Omics 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-cell Omics 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Single-cell Omics 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Single-cell Omics 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Single-cell Omics 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-cell Omics 麻豆原创 Size (2020-2031)
9.2 Latin America Single-cell Omics 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Single-cell Omics 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Single-cell Omics 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-cell Omics 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Single-cell Omics 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Single-cell Omics 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Single-cell Omics 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ANGLE Plc
11.1.1 ANGLE Plc Company Details
11.1.2 ANGLE Plc Business Overview
11.1.3 ANGLE Plc Single-cell Omics Introduction
11.1.4 ANGLE Plc Revenue in Single-cell Omics Business (2020-2025)
11.1.5 ANGLE Plc Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Single-cell Omics Introduction
11.2.4 BD Revenue in Single-cell Omics Business (2020-2025)
11.2.5 BD Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Single-cell Omics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Single-cell Omics Business (2020-2025)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Biognosys
11.4.1 Biognosys Company Details
11.4.2 Biognosys Business Overview
11.4.3 Biognosys Single-cell Omics Introduction
11.4.4 Biognosys Revenue in Single-cell Omics Business (2020-2025)
11.4.5 Biognosys Recent Development
11.5 CELLENION
11.5.1 CELLENION Company Details
11.5.2 CELLENION Business Overview
11.5.3 CELLENION Single-cell Omics Introduction
11.5.4 CELLENION Revenue in Single-cell Omics Business (2020-2025)
11.5.5 CELLENION Recent Development
11.6 CYTENA GmbH
11.6.1 CYTENA GmbH Company Details
11.6.2 CYTENA GmbH Business Overview
11.6.3 CYTENA GmbH Single-cell Omics Introduction
11.6.4 CYTENA GmbH Revenue in Single-cell Omics Business (2020-2025)
11.6.5 CYTENA GmbH Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Single-cell Omics Introduction
11.7.4 Danaher Corporation Revenue in Single-cell Omics Business (2020-2025)
11.7.5 Danaher Corporation Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Single-cell Omics Introduction
11.8.4 Illumina, Inc. Revenue in Single-cell Omics Business (2020-2025)
11.8.5 Illumina, Inc. Recent Development
11.9 Mission Bio
11.9.1 Mission Bio Company Details
11.9.2 Mission Bio Business Overview
11.9.3 Mission Bio Single-cell Omics Introduction
11.9.4 Mission Bio Revenue in Single-cell Omics Business (2020-2025)
11.9.5 Mission Bio Recent Development
11.10 PerkinElmer Inc.
11.10.1 PerkinElmer Inc. Company Details
11.10.2 PerkinElmer Inc. Business Overview
11.10.3 PerkinElmer Inc. Single-cell Omics Introduction
11.10.4 PerkinElmer Inc. Revenue in Single-cell Omics Business (2020-2025)
11.10.5 PerkinElmer Inc. Recent Development
11.11 Standard BioTools Inc.
11.11.1 Standard BioTools Inc. Company Details
11.11.2 Standard BioTools Inc. Business Overview
11.11.3 Standard BioTools Inc. Single-cell Omics Introduction
11.11.4 Standard BioTools Inc. Revenue in Single-cell Omics Business (2020-2025)
11.11.5 Standard BioTools Inc. Recent Development
11.12 Vizgen
11.12.1 Vizgen Company Details
11.12.2 Vizgen Business Overview
11.12.3 Vizgen Single-cell Omics Introduction
11.12.4 Vizgen Revenue in Single-cell Omics Business (2020-2025)
11.12.5 Vizgen Recent Development
11.13 10x Genomics
11.13.1 10x Genomics Company Details
11.13.2 10x Genomics Business Overview
11.13.3 10x Genomics Single-cell Omics Introduction
11.13.4 10x Genomics Revenue in Single-cell Omics Business (2020-2025)
11.13.5 10x Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

ANGLE Plc
BD
Bio-Rad Laboratories, Inc.
Biognosys
CELLENION
CYTENA GmbH
Danaher Corporation
Illumina, Inc.
Mission Bio
PerkinElmer Inc.
Standard BioTools Inc.
Vizgen
10x Genomics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.